Gabelli & Co Investment Advisers’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ETTX Stock Details ETTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-40,900	Closed	-$90K	–	537
2022 Q2	$90K	Hold	40,900	–	–	0.01%	358
2022 Q1	$76K	Buy	+40,900	New	+$74.5K	0.01%	384

Gabelli & Co Investment Advisers's ETTX Position: Q3 2022 in Review

Gabelli & Co Investment Advisers sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q3 2022, closing a stake of 40,900 shares — an estimated $90K sold.

Gabelli & Co Investment Advisers first reported a position in ETTX in Q1 2022 and held it in 2 quarters. The position peaked at $90K in Q2 2022. 0 funds tracked by Wall St. Rank hold ETTX as of Q3 2022.

Gabelli & Co Investment Advisers reported no remaining Entasis Therapeutics Holdings Inc. position as of Q3 2022 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 40,900 Entasis Therapeutics Holdings Inc. shares in Q3 2022, an estimated $90K.
Gabelli & Co Investment Advisers first reported a position in Entasis Therapeutics Holdings Inc. in Q1 2022 and held it in 2 quarters.
Gabelli & Co Investment Advisers's Entasis Therapeutics Holdings Inc. position peaked at $90K in Q2 2022.
0 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q3 2022.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2022, filed 10 Nov 2022.